News & analysis on the clinical development and manufacture of large molecule drugs
Operation Warp Speed, Moncef Slaoui
By Ben Hargreaves
- Last updated on
Earlier this month, the US government announced ‘Operation Warp Speed’ – which was set up to ready a potential vaccine for the novel coronavirus by the start of 2021.
In order to manage the project, Moncef Slaoui was brought on board as chief advisor. Previously, Slaoui held the role of chairman of R&D at GSK and chairman of its global vaccines division.
During his time leading GSK’s vaccines division, he oversaw the creation of 14 vaccines, including preventatives for shingles and malaria.
After leaving GSK, Slaoui became chairman at Galvani Bioelectronics and a partner at Medicxi Venture Capital.
Joining Slaoui is Gustave Perna, who will perform the role of chief operating officer. Perna is a general and commander of the US Army Material Command, with a history of working in the management and procurement of equipment and supplies for the US army.